OXYMIND: Oxytocin-augmented Group Psychotherapy for Patients With Schizophrenia
NCT06136390
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Schizophrenia Spectrum Disorders
Interventions
OTHER:
Oxytocin
OTHER:
Placebo
Sponsor
Charite University, Berlin, Germany